Skip to content

ENGNW

enGene Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · CA

$0.20
−13.04%
Ask drillr

Next report

Analyst consensus

Next report date
Dec 23, 2026
EPS estimate
-$0.46
Revenue estimate

Latest reported

Last report date
Sep 8, 2026
EPS actual
-$0.47
EPS estimate
-$0.43
Revenue actual
Revenue estimate

Track record

Trailing twelve quarters

EPS beats (12Q)
4
EPS misses (12Q)
1
EPS in line (12Q)
0
Avg surprise (4Q)
+188.7%
Revenue beats (12Q)
Earnings call history

No earnings call summaries available

Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Sep 8, 2026-$0.43-$0.47Miss -10.16%
Jun 15, 2026-$0.47-$0.43Beat 7.76%
Mar 9, 2026-$0.56$0.44Beat 179.04%
Dec 22, 2025-$0.57$2.71Beat 578.04%
Sep 11, 2025-$0.50$0.57Beat 213.86%

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Dec 28, 2026